Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence?

Obesity Surgery

Volumn 19, Issue 2, 2009, Pages 217-229

  Bose, Mousumi ^a,b   Oliván, Blanca ^a   Teixeira, Julio ^a   Pi Sunyer, F Xavier ^a   Laferrère, Blandine ^a  

^a Columbia University College of Physicians and Surgeons ^*  (United States)

^b ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

Author keywords

Diabetes; Gastric bypass; GIP; GLP 1; Incretin; Insulin; Weight loss

Indexed keywords

ANTIDIABETIC AGENT; DIPEPTIDYL PEPTIDASE IV INHIBITOR; GASTROINTESTINAL HORMONE; GHRELIN; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INCRETIN DERIV; INSULIN; LEPTIN; ORAL ANTIDIABETIC AGENT; PEPTIDE YY; UNCLASSIFIED DRUG;

BARIATRIC SURGERY; CALORIC RESTRICTION; DIET THERAPY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUTRIENT UPTAKE; OBESITY; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REMISSION; REVIEW; STOMACH BYPASS; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANIMALS; DIABETES MELLITUS, TYPE 2; EVIDENCE-BASED MEDICINE; GASTRIC BYPASS; GASTRIC EMPTYING; GASTRIC INHIBITORY POLYPEPTIDE; GHRELIN; GLUCAGON-LIKE PEPTIDE 1; GLUCONEOGENESIS; GLUCOSE; HOMEOSTASIS; HUMANS; INCRETINS; INTESTINE, SMALL; LEPTIN; LIVER; OBESITY, MORBID; PEPTIDE YY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; WEIGHT LOSS;

EID: 58649086097     PISSN: 09608923     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11695-008-9696-3     Document Type: Review

References (143)

1. Surgery ASMBS. Press release 8/22/2007: metabolic surgery expected to play bigger role in treating type 2 diabetes and other metabolic diseases. Gainesville, FL; 2007 [updated 2007; cited]; Available from: http://www.asbs.org/Newsite07/resources/press-release-8202007.pdf (2007).
2. Y Zhao W Encinosa Quality AfHRa 2007 Bariatric surgery utilization and outcomes in 1998 and 2004: statistical brief #23 Agency for Healthcare Research and Quality Rockville Zhao Y, Encinosa W, Quality AfHRa. Bariatric surgery utilization and outcomes in 1998 and 2004: statistical brief #23. Rockville: Agency for Healthcare Research and Quality; 2007. [updated 2007; cited 2008 May 9]; Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb23.pdf.
3. Anonymous. Methods for voluntary weight loss and control. NIH Technology Assessment Conference Panel. Consensus Development Conference, 30 March to 1 April 1992. Ann Intern Med 1993;119:764-70.
4. H Buchwald Y Avidor E Braunwald 2004 Bariatric surgery: a systematic review and meta-analysis JAMA 292 1724 1737
5. JB Dixon PE O'Brien J Playfair 2008 Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial JAMA 299 316 323
6. AL DePaula AL Macedo N Rassi 2008 Laparoscopic treatment of type 2 diabetes mellitus for patients with a body mass index less than 35 Surg Endosc 22 706 716
7. WJ Lee W Wang YC Lee 2008 Effect of laparoscopic mini-gastric bypass for type 2 diabetes mellitus: comparison of BMI >35 and <35 kg/m(2) J Gastrointest Surg 12 945 952
8. Stein R. Surgery shows promise for treatment of diabetes. Washington Post. 2008 May 4, 2008;Sect. 2.
9. R Fetner J McGinty C Russell 2005 Incretins, diabetes, and bariatric surgery: a review Surg Obes Relat Dis 1 589 597
10. SE Greenway FL Greenway 3rd S Klein 2002 Effects of obesity surgery on non-insulin-dependent diabetes mellitus Arch Surg 137 1109 1117
11. A Patriti E Facchiano A Sanna 2004 The enteroinsular axis and the recovery from type 2 diabetes after bariatric surgery Obes Surg 14 840 848
12. DE Cummings J Overduin MH Shannon 2005 Hormonal mechanisms of weight loss and diabetes resolution after bariatric surgery Surg Obes Relat Dis 1 358 368
13. D Maggs I MacDonald MA Nauck 2008 Glucose homeostasis and the gastrointestinal tract: insights into the treatment of diabetes Diabetes Obes Metab 10 18 33
14. L Quinn 2002 Mechanisms in the development of type 2 diabetes mellitus J Cardiovasc Nurs 16 1 16
15. JJ Holst 2007 The physiology of glucagon-like peptide 1 Physiol Rev 87 1409 1439
16. B Kreymann G Williams MA Ghatei 1987 Glucagon-like peptide-1 7-36: a physiological incretin in man Lancet 2 1300 1304
17. CF Deacon 2004 Circulation and degradation of GIP and GLP-1 Horm Metab Res 36 761 765
18. DJ Drucker 2003 Enhancing incretin action for the treatment of type 2 diabetes Diabetes Care 26 2929 2940
19. LL Kjems JJ Holst A Volund 2003 The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects Diabetes 52 380 386
20. DA Stoffers TJ Kieffer MA Hussain 2000 Insulinotropic glucagon-like peptide 1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas Diabetes 49 741 748
21. W Creutzfeldt R Ebert 1985 New developments in the incretin concept Diabetologia 28 565 573
22. DA D'Alessio TP Vahl 2004 Glucagon-like peptide 1: evolution of an incretin into a treatment for diabetes Am J Physiol Endocrinol Metab 286 E882 890
23. T Vilsboll JJ Holst 2004 Incretins, insulin secretion and Type 2 diabetes mellitus Diabetologia 47 357 366
24. J Buteau R Roduit S Susini 1999 Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells Diabetologia 42 856 864
25. HC Fehmann JF Habener 1992 Insulinotropic hormone glucagon-like peptide-I(7-37) stimulation of proinsulin gene expression and proinsulin biosynthesis in insulinoma beta TC-1 cells Endocrinology 130 159 166
26. M Zander S Madsbad JL Madsen 2002 Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study Lancet 359 824 830
27. E Naslund M Gutniak S Skogar 1998 Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men Am J Clin Nutr 68 525 530
28. MA Nauck U Niedereichholz R Ettler 1997 Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans Am J Physiol 273 E981 8
29. JJ Meier B Gallwitz S Salmen 2003 Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes J Clin Endocrinol Metab 88 2719 2725
30. WO Creutzfeldt N Kleine B Willms 1996 Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients Diabetes Care 19 580 586
31. A Hvidberg MT Nielsen J Hilsted 1994 Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man Metabolism 43 104 108
32. RL Prigeon S Quddusi B Paty 2003 Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect Am J Physiol Endocrinol Metab 285 E701 7
33. G Xu DA Stoffers JF Habener 1999 Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats Diabetes 48 2270 2276
34. K Moens H Heimberg D Flamez 1996 Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells Diabetes 45 257 261
35. P Huypens Z Ling D Pipeleers 2000 Glucagon receptors on human islet cells contribute to glucose competence of insulin release Diabetologia 43 1012 1019
36. Y Li T Hansotia B Yusta 2003 Glucagon-like peptide-1 receptor signaling modulates beta cell apoptosis J Biol Chem 278 471 478
37. MA Nauck E Homberger EG Siegel 1986 Incretin effects of increasing glucose loads in man calculated from venous insulin and C-peptide responses J Clin Endocrinol Metab 63 492 498
38. MA Nauck MM Heimesaat C Orskov 1993 Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus J Clin Invest 91 301 307
39. Hojberg PV, Vilsboll T, Knop FK, et al. Four weeks of near-normalization of blood glucose restores the insulin response to GIP and improves the insulin response to GLP-1 in patients with type 2 diabetes. American Diabetes Association 2007 Annual Meeting; 2007. American Diabetes Association; 2007.
40. MB Toft-Nielsen MB Damholt S Madsbad 2001 Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients J Clin Endocrinol Metab 86 3717 3723
41. K Vollmer JJ Holst B Baller 2008 Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance Diabetes 57 678 687
42. M Toft-Nielson S Madsbad JJ Holst 1996 The effect of glucagon-like peptide I (GLP-I) on glucose elimination in healthy subjects depends on the pancreatic glucoregulatory hormones Diabetes 45 552 556
43. S Madsbad T Krarup CF Deacon 2008 Glucagon-like peptide receptor agonists and dipeptidyl peptidase-4 inhibitors in the treatment of diabetes: a review of clinical trials Curr Opin Clin Nutr Metab Care 11 491 499
44. EE Mason 1982 Vertical banded gastroplasty for obesity Arch Surg 117 701 706
45. AA Saber MH Elgamal MK McLeod 2008 Bariatric surgery: the past, present, and future Obes Surg 18 121 128
46. RE Brolin 2002 Bariatric surgery and long-term control of morbid obesity JAMA 288 2793 2796
47. Anonymous. Overweight, obesity, and health risk. National Task Force on the Prevention and Treatment of Obesity. Arch Intern Med 2000;160:898-904.
48. C Berne 2005 A randomized study of orlistat in combination with a weight management programme in obese patients with Type 2 diabetes treated with metformin Diabet Med 22 612 618
49. M Fukuda Y Tahara Y Yamamoto 1989 Effects of very-low-calorie diet weight reduction on glucose tolerance, insulin secretion, and insulin resistance in obese non-insulin-dependent diabetics Diabetes Res Clin Pract 7 61 67
50. B Gumbiner KS Polonsky WF Beltz 1990 Effects of weight loss and reduced hyperglycemia on the kinetics of insulin secretion in obese non-insulin dependent diabetes mellitus J Clin Endocrinol Metab 70 1594 1602
51. JB Redmon SK Raatz KP Reck 2003 One-year outcome of a combination of weight loss therapies for subjects with type 2 diabetes: a randomized trial Diabetes Care 26 2505 2511
52. R Ross D Dagnone PJ Jones 2000 Reduction in obesity and related comorbid conditions after diet-induced weight loss or exercise-induced weight loss in men. A randomized, controlled trial Ann Intern Med 133 92 103
53. RR Wing MD Marcus R Salata 1991 Effects of a very-low-calorie diet on long-term glycemic control in obese type 2 diabetic subjects Arch Intern Med 151 1334 1340
54. RR Henry L Scheaffer JM Olefsky 1985 Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 61 917 925
55. CD Sjostrom L Lissner H Wedel 1999 Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study Obes Res 7 477 484
56. A Brancatisano S Wahlroos S Matthews 2008 Gastric banding for the treatment of type 2 diabetes mellitus in morbidly obese Surg Obes Relat Dis 4 423 429
57. AE Pontiroli P Pizzocri MC Librenti 2002 Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study J Clin Endocrinol Metab 87 3555 3561
58. RE Barry J Barisch GA Bray 1977 Intestinal adaptation after jejunoileal bypass in man Am J Clin Nutr 30 32 42
59. JM Kellum JF Kuemmerle TM O'Dorisio 1990 Gastrointestinal hormone responses to meals before and after gastric bypass and vertical banded gastroplasty Ann Surg 211 763 770
60. E Naslund L Backman JJ Holst 1998 Importance of small bowel peptides for the improved glucose metabolism 20 years after jejunoileal bypass for obesity Obes Surg 8 253 260
61. F Rubino M Gagner P Gentileschi 2004 The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism Ann Surg 240 236 242
62. B Laferrere J Teixeira J McGinty 2008 Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes J Clin Endocrinol Metab 93 2479 2485
63. RH Clements QH Gonzalez CI Long 2004 Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus Am Surg 70 1 4
64. B Laferrere S Heshka K Wang 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diabetes Care 30 1709 1716
65. I Valverde J Puente A Martin-Duce 2005 Changes in glucagon-like peptide-1 (GLP-1) secretion after biliopancreatic diversion or vertical banded gastroplasty in obese subjects Obes Surg 15 387 397
66. C Guidone M Manco E Valera-Mora 2006 Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery Diabetes 55 2025 2031
67. T Reinehr CL Roth GH Schernthaner 2007 Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss Obes Surg 17 1571 1577
68. R Morinigo AM Lacy R Casamitjana 2006 GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects Obes Surg 16 1594 1601
69. R Morinigo V Moize M Musri 2006 Glucagon-like peptide-1, peptide YY, hunger, and satiety after gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 91 1735 1740
70. CM Borg CW le Roux MA Ghatei 2006 Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety Br J Surg 93 210 215
71. CW le Roux R Welbourn M Werling 2007 Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass Ann Surg 246 780 785
72. Laferrere B, Tran H, Egger JR, et al. The increase in GLP-1 levels and incretin effect after Roux-en-Y Gastric Bypass Surgery (RYGBP) persists up to 1 year in patients with Type 2 Diabetes Mellitus (T2DM). 2007 The Obesity Society Annual Meeting; 2007 October 20, 2007; New Orleans, LA. Nature Publishing Group; 2007. p. A7.
73. J Korner M Bessler W Inabnet 2007 Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding Surg Obes Relat Dis 3 597 601
74. F Rodieux V Giusti DA D'Alessio 2008 Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release Obesity (Silver Spring) 16 298 305
75. JR Shak J Roper GI Perez-Perez 2008 The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones Obes Surg 18 1097 1098
76. KR Sirinek TM O'Dorisio D Hill 1986 Hyperinsulinism, glucose-dependent insulinotropic polypeptide, and the enteroinsular axis in morbidly obese patients before and after gastric bypass Surgery 100 781 787
77. R Jorde PG Burhol JA Johnson 1981 The effect of jejunoileal bypass on postprandial release of plasma gastric inhibitory polypeptide (GIP) Scand J Gastroenterol 16 313 319
78. AB Goldfine EC Mun E Devine 2007 Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal J Clin Endocrinol Metab 92 4678 4685
79. S Klein B Mittendorfer JC Eagon 2006 Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease Gastroenterology 130 1564 1572
80. RR Henry P Wallace JM Olefsky 1986 Effects of weight loss on mechanisms of hyperglycemia in obese non-insulin-dependent diabetes mellitus Diabetes 35 990 998
81. RR Henry G Brechtel K Griver 1988 Secretion and hepatic extraction of insulin after weight loss in obese noninsulin-dependent diabetes mellitus J Clin Endocrinol Metab 66 979 986
82. OG Kolterman JB Buse MS Fineman 2003 Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes J Clin Endocrinol Metab 88 3082 3089
83. GH Ballantyne D Farkas S Laker 2006 Short-term changes in insulin resistance following weight loss surgery for morbid obesity: laparoscopic adjustable gastric banding versus laparoscopic Roux-en-Y gastric bypass Obes Surg 16 1189 1197
84. WJ Lee YC Lee KH Ser 2008 Improvement of insulin resistance after obesity surgery: a comparison of gastric banding and bypass procedures Obes Surg 18 1119 1125
85. EV Polyzogopoulou F Kalfarentzos AG Vagenakis 2003 Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery Diabetes 52 1098 1103
86. K Wickremesekera G Miller TD Naotunne 2005 Loss of insulin resistance after Roux-en-Y gastric bypass surgery: a time course study Obes Surg 15 474 481
87. A Mari M Manco C Guidone 2006 Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function Diabetologia 49 2136 2143
88. JA Pereira MA Lazarin JC Pareja 2003 Insulin resistance in nondiabetic morbidly obese patients: effect of bariatric surgery Obes Res 11 1495 1501
89. B Geloneze MA Tambascia JC Pareja 2001 The insulin tolerance test in morbidly obese patients undergoing bariatric surgery Obes Res 9 763 769
90. AM van den Hoek AC Heijboer PJ Voshol 2007 Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice Am J Physiol Endocrinol Metab 292 E238 245
91. N Vrang AN Madsen M Tang-Christensen 2006 PYY(3-36) reduces food intake and body weight and improves insulin sensitivity in rodent models of diet-induced obesity Am J Physiol Regul Integr Comp Physiol 291 R367 375
92. Y Sun M Asnicar PK Saha 2006 Ablation of ghrelin improves the diabetic but not obese phenotype of ob/ob mice Cell Metab 3 379 386
93. B Ahren G Pacini 2004 Importance of quantifying insulin secretion in relation to insulin sensitivity to accurately assess beta cell function in clinical studies Eur J Endocrinol 150 97 104
94. JD Brunzell RP Robertson RL Lerner 1976 Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests J Clin Endocrinol Metab 42 222 229
95. Y Yoshida N Hashimoto Y Tokuyama 2004 Effects of weight loss in obese subjects with normal fasting plasma glucose or impaired glucose tolerance on insulin release and insulin resistance according to a minimal model analysis Metabolism 53 1095 1100
96. L Briatore B Salani G Andraghetti 2008 Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion Obesity (Silver Spring) 16 77 81
97. MR Letiexhe AJ Scheen PL Gerard 1994 Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects Int J Obes Relat Metab Disord 18 295 300
98. M Guldstrand B Ahren U Adamson 2003 Improved beta-cell function after standardized weight reduction in severely obese subjects Am J Physiol Endocrinol Metab 284 E557 565
99. F Fehse M Trautmann JJ Holst 2005 Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes J Clin Endocrinol Metab 90 5991 5997
100. TP Vahl BW Paty BD Fuller 2003 Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans J Clin Endocrinol Metab 88 1772 1779
101. D Porte Jr 1991 Banting lecture 1990. Beta-cells in type II diabetes mellitus Diabetes 40 166 180
102. RA DeFronzo 1988 Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM Diabetes 37 667 687
103. FX Pi-Sunyer 1996 Weight and non-insulin-dependent diabetes mellitus Am J Clin Nutr 63 426S 429S
104. C Verdich S Toubro B Buemann 2001 The role of postprandial releases of insulin and incretin hormones in meal-induced satiety-effect of obesity and weight reduction Int J Obes Relat Metab Disord 25 1206 1214
105. AD Strader TP Vahl RJ Jandacek 2005 Weight loss through ileal transposition is accompanied by increased ileal hormone secretion and synthesis in rats Am J Physiol Endocrinol Metab 288 E447 53
106. A Patriti E Facchiano C Annetti 2005 Early improvement of glucose tolerance after ileal transposition in a non-obese type 2 diabetes rat model Obes Surg 15 1258 1264
107. A Patriti MC Aisa C Annetti 2007 How the hindgut can cure type 2 diabetes. Ileal transposition improves glucose metabolism and beta-cell function in Goto-Kakizaki rats through an enhanced Proglucagon gene expression and L-cell number Surgery 142 74 85
108. MS Hickey WJ Pories KG MacDonald Jr 1998 A new paradigm for type 2 diabetes mellitus: could it be a disease of the foregut? Ann Surg 227 637 643
109. F Rubino J Marescaux 2004 Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease Ann Surg 239 1 11
110. F Rubino A Forgione DE Cummings 2006 The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes Ann Surg 244 741 749
111. TT Wang SY Hu HD Gao 2008 Ileal transposition controls diabetes as well as modified duodenal jejunal bypass with better lipid lowering in a nonobese rat model of type II diabetes by increasing GLP-1 Ann Surg 247 968 975
112. D Pacheco DA de Luis A Romero 2007 The effects of duodenal-jejunal exclusion on hormonal regulation of glucose metabolism in Goto-Kakizaki rats Am J Surg 194 221 224
113. M Horowitz PJ Collins PE Harding 1986 Gastric emptying after gastric bypass Int J Obes 10 117 121
114. I Naslund KW Beckman 1987 Gastric emptying rate after gastric bypass and gastroplasty Scand J Gastroenterol 22 193 201
115. DP Kotler D Sherman SR Bloom 1985 Malnutrition after gastric surgery. Association with exaggerated distal intestinal hormone release Dig Dis Sci 30 193 199
116. MR Druce AM Wren AJ Park 2005 Ghrelin increases food intake in obese as well as lean subjects Int J Obes (Lond) 29 1130 1136
117. B Laferrere AB Hart CY Bowers 2006 Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake Obesity (Silver Spring) 14 1056 1063
118. DE Cummings DS Weigle RS Frayo 2002 Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery N Engl J Med 346 1623 1630
119. EV Kotidis GG Koliakos VG Baltzopoulos 2006 Serum ghrelin, leptin and adiponectin levels before and after weight loss: comparison of three methods of treatment-a prospective study Obes Surg 16 1425 1432
120. JL Chan EC Mun V Stoyneva 2006 Peptide YY levels are elevated after gastric bypass surgery Obesity (Silver Spring) 14 194 198
121. R Morinigo R Casamitjana V Moize 2004 Short-term effects of gastric bypass surgery on circulating ghrelin levels Obes Res 12 1108 1116
122. CW le Roux SJ Aylwin RL Batterham 2006 Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters Ann Surg 243 108 114
123. M Faraj PJ Havel S Phelis 2003 Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects J Clin Endocrinol Metab 88 1594 1602
124. F Broglio E Arvat A Benso 2001 Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans J Clin Endocrinol Metab 86 5083 5086
125. F Broglio C Gottero F Prodam 2004 Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans J Clin Endocrinol Metab 89 3062 3065
126. RL Batterham MA Cohen SM Ellis 2003 Inhibition of food intake in obese subjects by peptide YY3-36 N Engl J Med 349 941 948
127. RL Batterham MA Cowley CJ Small 2002 Gut hormone PYY(3-36) physiologically inhibits food intake Nature 418 650 654
128. J Korner M Bessler LJ Cirilo 2005 Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin J Clin Endocrinol Metab 90 359 365
129. R Morinigo J Vidal AM Lacy 2008 Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects Ann Surg 247 270 275
130. E Jequier 2002 Leptin signaling, adiposity, and energy balance Ann N Y Acad Sci 967 379 388
131. PJ Havel 2000 Role of adipose tissue in body-weight regulation: mechanisms regulating leptin production and energy balance Proc Nutr Soc 59 359 371
132. B Geloneze MA Tambascia JC Pareja 2001 Serum leptin levels after bariatric surgery across a range of glucose tolerance from normal to diabetes Obes Surg 11 693 698
133. J Korner W Inabnet IM Conwell 2006 Differential effects of gastric bypass and banding on circulating gut hormone and leptin levels Obesity (Silver Spring) 14 1553 1561
134. L Angrisani M Lorenzo V Borrelli 2007 Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial Surg Obes Relat Dis 3 127 132
135. L Sjostrom K Narbro CD Sjostrom 2007 Effects of bariatric surgery on mortality in Swedish obese subjects N Engl J Med 357 741 752
136. P Schauer B Chand S Brethauer 2007 New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery Surg Endosc 21 347 356
137. WJ Pories KG MacDonald Jr EJ Morgan 1992 Surgical treatment of obesity and its effect on diabetes: 10-y follow-up Am J Clin Nutr 55 582S 585S
138. JE Poulos N Leggett-Frazier P Khazanie 1994 Circulating insulin-like growth factor I concentrations in clinically severe obese patients with and without NIDDM in response to weight loss Horm Metab Res 26 478 480
139. PR Schauer B Burguera S Ikramuddin 2003 Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus Ann Surg 238 467 484
140. F Diniz Mde MT Diniz SR Sanches 2004 Glycemic control in diabetic patients after bariatric surgery Obes Surg 14 1051 1055
141. TK Alexandrides G Skroubis F Kalfarentzos 2007 Resolution of diabetes mellitus and metabolic syndrome following Roux-en-Y gastric bypass and a variant of biliopancreatic diversion in patients with morbid obesity Obes Surg 17 176 184
142. E Schrumpf A Bergan O Djoseland 1985 The effect of gastric bypass operation on glucose tolerance in obesity Scand J Gastroenterol Suppl 107 24 31
143. BA Whitson DB Leslie TA Kellogg 2007 Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study J Surg Res 141 31 39